Search Results - "glucose"
Suggested Topics within your search.
Suggested Topics within your search.
- Cancer
- Neoplasms 8
- Pathophysiology 6
- physiology 6
- physiopathology 6
- Glucose 5
- metabolism 5
- Acetylglucosamine 3
- Carcinoma, Renal Cell 3
- Cell Cycle 3
- Cell Physiological Phenomena 3
- Cell cycle 3
- Cellular signal transduction 3
- DNA Damage 3
- DNA Repair 3
- Degeneration 3
- Diseases 3
- Genetic aspects 3
- Genetics 3
- Genetics, Medical 3
- Glucosamine 3
- Glycosylation 3
- Inhibitors 3
- Kidney Diseases 3
- Kidney Neoplasms 3
- Kidneys 3
- Medical genetics 3
- Metabolic Diseases 3
- Nervous system 3
- Neurodegenerative Diseases 3
-
1
O-GlcNAc, an essential regulator of numerous cellular pathways
Published 2014Subjects: Get full text
Series
Electronic Video -
2
O-GlcNAc, an essential regulator of numerous cellular pathways
Published 2014Subjects: Get full text
Series
Electronic Video -
3
O-GlcNAc, an essential regulator of numerous cellular pathways
Published 2014Subjects: Get full text
Series
Electronic Video -
4
Roles of AMPK in energy homeostasis and nutrient sensing
Published 2021Subjects: Get full text
Series
Electronic Video -
5
Roles of AMPK in energy homeostasis and nutrient sensing
Published 2021Subjects: Get full text
Series
Electronic Video -
6
PI3K/AKT signaling In cancer
Published 2011Table of Contents: “…Contents: PI3K/AKT signal transduction pathway -- Tumors with frequent dysregulation of PI3K signalling -- Modalities for inhibiting PI3K-AKT signaling currently in development -- AKT1/2 inhibitor (Merck) -- PI3K/AKT in breast cancer -- AKTi-1/2 inhibits AKT signaling and causes G1 arrest -- The Herceptin-resistant -- Effect of AKT inhibition on glucose levels -- Mutated elements in mitogenic signaling pathways in tumors -- Coexistent K-Ras or B-Raf mutation -- Genes encoding several components of mitogenic signaling pathways are mutationally activated in tumors -- Integrators of multiple signaling pathways (OR-gates) -- The effects of combined inhibition of AKT and MAPK on the phosphorylation of translational regulatory proteins -- Knockdown of 4EBP1 expression -- Feedback inhibition of insulin/IGF-1 signaling -- The concept of feedback -- Clinical effects of Rapamycin-like drugs -- mTORC1 vs. …”
Get full text
Series
Electronic Video -
7
PI3K/AKT signaling In cancer
Published 2011Table of Contents: “…Contents: PI3K/AKT signal transduction pathway -- Tumors with frequent dysregulation of PI3K signalling -- Modalities for inhibiting PI3K-AKT signaling currently in development -- AKT1/2 inhibitor (Merck) -- PI3K/AKT in breast cancer -- AKTi-1/2 inhibits AKT signaling and causes G1 arrest -- The Herceptin-resistant -- Effect of AKT inhibition on glucose levels -- Mutated elements in mitogenic signaling pathways in tumors -- Coexistent K-Ras or B-Raf mutation -- Genes encoding several components of mitogenic signaling pathways are mutationally activated in tumors -- Integrators of multiple signaling pathways (OR-gates) -- The effects of combined inhibition of AKT and MAPK on the phosphorylation of translational regulatory proteins -- Knockdown of 4EBP1 expression -- Feedback inhibition of insulin/IGF-1 signaling -- The concept of feedback -- Clinical effects of Rapamycin-like drugs -- mTORC1 vs. …”
Get full text
Series
Electronic Video -
8
PI3K/AKT signaling In cancer
Published 2011Table of Contents: “…Contents: PI3K/AKT signal transduction pathway -- Tumors with frequent dysregulation of PI3K signalling -- Modalities for inhibiting PI3K-AKT signaling currently in development -- AKT1/2 inhibitor (Merck) -- PI3K/AKT in breast cancer -- AKTi-1/2 inhibits AKT signaling and causes G1 arrest -- The Herceptin-resistant -- Effect of AKT inhibition on glucose levels -- Mutated elements in mitogenic signaling pathways in tumors -- Coexistent K-Ras or B-Raf mutation -- Genes encoding several components of mitogenic signaling pathways are mutationally activated in tumors -- Integrators of multiple signaling pathways (OR-gates) -- The effects of combined inhibition of AKT and MAPK on the phosphorylation of translational regulatory proteins -- Knockdown of 4EBP1 expression -- Feedback inhibition of insulin/IGF-1 signaling -- The concept of feedback -- Clinical effects of Rapamycin-like drugs -- mTORC1 vs. …”
Get full text
Series
Electronic Video -
9
The genetic basis of kidney cancer
Published 2014Table of Contents: “…-- Folliculin-FNIP1/2-AMPK interactions -- mTORC1/mTORC2 activation: FLCN-deficient Kidney Cancer -- BHD deletion specifically in the kidney -- BHDf/d/KSPCre mouse kidney study -- Hereditary Leiomyomatosis Renal Cell Carcinoma (HLRCC) -- HLRCC: cutaneous manifestations, Uterine Leiomyomas -- HLRCC: Papillary Kidney Cancer Type 2 -- Orangophilic nucleoli + Perinucleolar halos -- Fumarate Hydratase gene: HLRCC -- UOK-262 study -- Loss of a Krebs Cycle Enzyme can lead to Kidney Cancer -- Impaired citric acid cycle and "Warburg effect" -- HLRCC-Renal Cancer: glucose-dependent -- PET scan -- HLRCC novel treatment approaches -- Kidney cancer: a metabolic disease.…”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)
Electronic Video -
10
The genetic basis of kidney cancer
Published 2014Table of Contents: “…-- Folliculin-FNIP1/2-AMPK interactions -- mTORC1/mTORC2 activation: FLCN-deficient Kidney Cancer -- BHD deletion specifically in the kidney -- BHDf/d/KSPCre mouse kidney study -- Hereditary Leiomyomatosis Renal Cell Carcinoma (HLRCC) -- HLRCC: cutaneous manifestations, Uterine Leiomyomas -- HLRCC: Papillary Kidney Cancer Type 2 -- Orangophilic nucleoli + Perinucleolar halos -- Fumarate Hydratase gene: HLRCC -- UOK-262 study -- Loss of a Krebs Cycle Enzyme can lead to Kidney Cancer -- Impaired citric acid cycle and "Warburg effect" -- HLRCC-Renal Cancer: glucose-dependent -- PET scan -- HLRCC novel treatment approaches -- Kidney cancer: a metabolic disease.…”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)
Electronic Video -
11
The genetic basis of kidney cancer
Published 2014Table of Contents: “…-- Folliculin-FNIP1/2-AMPK interactions -- mTORC1/mTORC2 activation: FLCN-deficient Kidney Cancer -- BHD deletion specifically in the kidney -- BHDf/d/KSPCre mouse kidney study -- Hereditary Leiomyomatosis Renal Cell Carcinoma (HLRCC) -- HLRCC: cutaneous manifestations, Uterine Leiomyomas -- HLRCC: Papillary Kidney Cancer Type 2 -- Orangophilic nucleoli + Perinucleolar halos -- Fumarate Hydratase gene: HLRCC -- UOK-262 study -- Loss of a Krebs Cycle Enzyme can lead to Kidney Cancer -- Impaired citric acid cycle and "Warburg effect" -- HLRCC-Renal Cancer: glucose-dependent -- PET scan -- HLRCC novel treatment approaches -- Kidney cancer: a metabolic disease.…”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)
Electronic Video